Zobrazeno 1 - 10
of 90
pro vyhledávání: '"R, van't Hof"'
Autor:
Arun Kumar, Pamela L. Lutsey, Wendy L. St. Peter, Jon C. Schommer, Jeremy R. Van’t Hof, Abhijeet Rajpurohit, Joel F. Farley
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 10, Pp 1886-1897 (2023)
Abstract P2Y12 inhibitors (i.e., clopidogrel, prasugrel, or ticagrelor) are effective at reducing adverse cardiovascular outcomes post‐revascularization in coronary artery disease (CAD). However, the choice of a specific P2Y12 inhibitor may vary ac
Externí odkaz:
https://doaj.org/article/e002a9f3ca84407dbaaec17fcc20257e
Autor:
Kentaro Ejiri, Ning Ding, Esther Kim, Yasuyuki Honda, Miguel Cainzos‐Achirica, Hirofumi Tanaka, Candace M. Howard‐Claudio, Kenneth R. Butler, Timothy M. Hughes, Jeremy R. Van't Hof, Michelle L. Meyer, Michael J. Blaha, Kunihiro Matsushita
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 2 (2024)
Background Pulse wave velocity (PWV) is a noninvasive measure of arterial stiffness and predictor of cardiovascular disease. However, the association between PWV and vascular calcification across different vascular beds has not been fully investigate
Externí odkaz:
https://doaj.org/article/9ff199a66ea44fbe80a60cee758964f0
Autor:
Sarah M. Alabsi, Sue Duval, Michael Sundberg, Donovan Williams, Russell V. Luepker, Milton Eder, Jeremy R. Van't Hof
Publikováno v:
Preventive Medicine Reports, Vol 37, Iss , Pp 102571- (2024)
Despite high prevalence of cardiovascular disease (CVD) and CVD risk factors among American Indian or Alaska Native adults (AI/AN), there is little information on aspirin use in this population. This survey-based study seeks to understand prevalence
Externí odkaz:
https://doaj.org/article/483e944761924c689d392581f3d868cc
Autor:
David M. Harmon, Demilade Adedinsewo, Jeremy R. Van't Hof, Matthew Johnson, Sharonne N. Hayes, Francisco Lopez-Jimenez, Clarence Jones, Zachi I. Attia, Paul A. Friedman, Christi A. Patten, Lisa A. Cooper, LaPrincess C. Brewer
Publikováno v:
American Journal of Preventive Cardiology, Vol 12, Iss , Pp 100431- (2022)
Objective: With the emergence of artificial intelligence (AI)-based health interventions, systemic racism remains a concern as these advancements are frequently developed without race-specific data analysis or validation. To evaluate the potential ut
Externí odkaz:
https://doaj.org/article/6397e9f918784c22b13e6ecc5f33380b
Autor:
Jeremy R. Van't Hof, Wendy Wang, Kunihiro Matsushita, Gerardo Heiss, Aaron R. Folsom, Rachel Widome, Pamela L. Lutsey
Publikováno v:
American Journal of Preventive Medicine. 64:728-733
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c35de9c972a032a9b044ff5973a9655f
https://doi.org/10.1016/j.amepre.2023.01.001
https://doi.org/10.1016/j.amepre.2023.01.001
Autor:
Sue Duval, Jeremy R. Van't Hof, Niki C. Oldenburg, Milton Eder, John R. Finnegan, Jr., Russell V. Luepker
Publikováno v:
Contemporary Clinical Trials Communications, Vol 22, Iss , Pp 100772- (2021)
Background: USPSTF evidence-based recommendations for the use of low-dose aspirin for primary prevention of cardiovascular disease were published in 2009. We describe a statewide campaign using innovative methods to educate the public and health comm
Externí odkaz:
https://doaj.org/article/4f9a0528f0f3473aae0b721e401efccc
Autor:
Arun Kumar, Pamela L. Lutsey, Wendy L. St. Peter, Jon C. Schommer, Jeremy R. Van't Hof, Abhijeet Rajpurohit, Joel F. Farley
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:412-422
In closely monitored randomized controlled trials (RCTs), newer P2Y12 agents (ticagrelor and prasugrel) reduced cardiovascular outcomes compared to clopidogrel following percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS). Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17cc9e6c7589fd4737b6bdc8d64ac2f9
https://doi.org/10.1002/cpt.2806
https://doi.org/10.1002/cpt.2806
Autor:
Arun Kumar, Pamela L. Lutsey, Wendy L. St Peter, Jon C. Schommer, Jeremy R. Van't Hof, Abhijeet Rajpurohit, Joel F. Farley
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:401-411
Comparative effectiveness evaluation of newer P2Y12 inhibitors (prasugrel and ticagrelor) compared to clopidogrel after acute coronary syndrome (ACS) is limited in real-world US populations. The objective of this study was to evaluate cardiovascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ebc4f3c7fbf5a51fad6893b4aa949bb
https://doi.org/10.1002/cpt.2797
https://doi.org/10.1002/cpt.2797
Autor:
Romil R. Parikh, Riccardo M. Inciardi, Wendy Wang, Sheila M. Hegde, Faye L. Norby, Michael J. Zhang, Jorge L. Reyes, Jeremy R. Van’t Hof, Alvaro Alonso, Amil M. Shah, Scott D. Solomon, Lin Yee Chen
Publikováno v:
JACC: Cardiovascular Imaging. 16:566-568
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::594fce3ad1b8f38d955109038eb5fa11
https://doi.org/10.1016/j.jcmg.2022.10.026
https://doi.org/10.1016/j.jcmg.2022.10.026
Autor:
Jeremy R. Van’t Hof, Sue Duval, Russell V. Luepker, Clarence Jones, Sharonne N. Hayes, Lisa A. Cooper, Christi A. Patten, LaPrincess C. Brewer
Publikováno v:
Mayo Clin Proc
To assess cardiovascular disease (CVD) and CVD risk factors and their association with sociodemographic characteristics and health beliefs among African American (AA) adults in Minnesota.A cross-sectional analysis was conducted of a community-based s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21fe770e85035058a419eb8880cfea6e
https://doi.org/10.1016/j.mayocp.2021.08.027
https://doi.org/10.1016/j.mayocp.2021.08.027